Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Foundation Medicine Collaboration by Quarter
Foundation Medicine Collaboration — Current Contract Liability ($M) [legacy through Q3 2025] ($M)
Natera Foundation Medicine Collaboration: $1.70M in Q3 2025, down 43.3% from a year earlier.
Where the Q3 2025 figure comes from
Source: Form 10-Q (2025-11-07) ↗
Reported in Form 10-K/10-Q Note — Collaborative & Licensing Arrangements (2019–2025Q3).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Foundation Medicine Collaboration — Current Contract Liability ($M) [legacy through Q3 2025] ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2025 | Sep 30, 2025 | 1.70 | -43.3% | Form 10-Q (2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 1.70 | -43.3% | Form 10-Q (2025-08-08) ↗ |
| Q1 2025 | Mar 31, 2025 | 1.50 | -6.2% | Form 10-Q (2025-05-09) ↗ |
| Q4 2024 | Dec 31, 2024 | 1.70 | 0.0% | Form 10-K (2025-02-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 3 | +36.4% | Form 10-Q (2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 3 | +30.4% | Form 10-Q (2024-08-09) ↗ |
| Q1 2024 | Mar 31, 2024 | 1.60 | -33.3% | Form 10-Q (2024-05-10) ↗ |
| Q4 2023 | Dec 31, 2023 | 1.70 | – | Form 10-K (2024-02-29) ↗ |
| Q3 2023 | Sep 30, 2023 | 2.20 | – | Form 10-Q (2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 2.30 | +64.3% | Form 10-Q (2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 2.40 | +50.0% | Form 10-Q (2023-05-10) ↗ |
| Q2 2022 | Jun 30, 2022 | 1.40 | -72.5% | Form 10-Q (2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 1.60 | -61.9% | Form 10-Q (2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 0.50 | -91.9% | Form 10-K (2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 3.70 | -47.1% | Form 10-Q (2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 5.10 | – | Form 10-Q (2021-08-06) ↗ |
| Q1 2021 | Mar 31, 2021 | 4.20 | – | Form 10-Q (2021-05-07) ↗ |
| Q4 2020 | Dec 31, 2020 | 6.20 | – | Form 10-K (2021-02-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 7 | -32.6% | Form 10-Q (2020-11-06) ↗ |
| Q3 2019 | Sep 30, 2019 | 10.4 | – | Form 10-Q (2019-11-08) ↗ |
Cite this data
StockData. (2026). Natera Foundation Medicine Collaboration ($M), quarterly Q3 2019–Q3 2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/contract-liab-fmi-current
See every metric in the Natera KPI table. Data updated Nov 2, 2026.